Fragile X News Today

Recent Posts

• McQuade Center, Sentinel Oncology Working on New Therapy
• New Institute Aims to Leave No Rare Disease Patient Behind
• Group Focuses on Rare Disease Clinical Trial Participation
• ‘Running for Rare’: NORD a Charity Partner of 2021 NYC Marathon
• Anavex2-73 Shows Efficacy in Fragile X Mouse Study, Phase 2/3 Trial Planned
• CDC Funds Five-year Study to Better Define Fragile X Natural History
• ‘Not Alone in the Dark’: New Guide for, by Caregivers of Children With Rare Diseases
• EU Orphan Drug Status Sought for Nova Therapy Using Hallucinogenic Psilocybin
• Register Now for Global Genes’ RARE Patient Advocacy Summit
• NORD Rare Disease Summit, Online Oct. 18-19, Open for Registration